CDNA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
131.9M
+12.1%
117.7M
+8.6%
108.4M
+8.3%
100.1M
+15.4%
86.7M
Cost of Revenue
35.0M
+4.0%
33.6M
-5.3%
35.5M
+15.8%
30.7M
+7.0%
28.7M
Gross Profit
97.0M
+15.4%
84.1M
+15.4%
72.9M
+5.0%
69.4M
+19.6%
58.0M
Operating Expenses
96.7M
+16.7%
82.9M
+5.0%
78.9M
+13.3%
69.6M
+0.7%
69.1M
R&D
22.4M
+4.5%
21.4M
+10.9%
19.3M
+15.1%
16.8M
-0.4%
16.8M
SG&A
74.3M
+22.2%
60.9M
+2.1%
59.6M
+12.7%
52.9M
+1.8%
52.0M
Operating Income
257.0K
-78.5%
1.2M
+119.8%
-6040000
-2355.3%
-246000
+97.8%
-11121000
EBITDA
3.1M
-46.1%
5.7M
+364.0%
-2158000
-160.5%
3.6M
+150.6%
-7049000
Net Income
110.6M
+3838.6%
2.8M
+168.4%
-4108000
-345.3%
1.7M
+119.5%
-8568000
EPS (Basic)
$2.15
+4200.0%
$0.05
+162.5%
$-0.08
-366.7%
$0.03
+118.8%
$-0.16
EPS (Diluted)
$2.07
+4040.0%
$0.05
+162.5%
$-0.08
-366.7%
$0.03
+118.8%
$-0.16
Shares (Diluted)
53.4M
+0.6%
53.1M
+6.6%
49.8M
-7.2%
53.7M
-1.0%
54.3M
CareDx (CDNA) โ€” Financials